Related Experiment Video
Updated: Jun 23, 2025
04:05
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
1.8K
Full decongestion in acute heart failure therapy
Chandan Buttar1, Hamid Alai1, Faris N Matanes1
1Department of Cardiology, Tulane University Medical Center, 1415 Tulane Ave, New Orleans, LA 70112, USA; Southeast Louisiana Veterans Healthcare System, 2400 Canal Street, New Orleans, LA 70119, USA.
The American Journal of the Medical Sciences
|June 16, 2024
Summary
Achieving complete decongestion is crucial for acute heart failure patients to prevent early readmission. Quadruple therapy is recommended, but its full benefit, especially for beta blockers and ARNI, is realized after decongestion is complete.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Incomplete decongestion is a primary driver of early hospital readmissions for acute heart failure.
- Current heart failure guidelines advocate for rapid initiation of quadruple therapy in heart failure with reduced ejection fraction.
Purpose of the Study:
- To clarify the optimal timing for initiating and up-titrating quadruple therapy in acute heart failure management.
- To emphasize the paramount importance of achieving complete decongestion during hospitalization.
Main Methods:
- Review of recent heart failure guidelines and therapeutic strategies.
- Analysis of the role of quadruple therapy components in relation to decongestion status.
Main Results:
- While early introduction of SGLT2 inhibitors and MRAs may be beneficial, the full therapeutic value of ARNIs and beta blockers is contingent upon complete decongestion.
- Complete decongestion remains the primary objective of acute heart failure hospitalization.
Conclusions:
- Prioritize achieving complete decongestion in acute heart failure patients.
- Consider the timing of quadruple therapy initiation, with ARNIs and beta blockers optimally utilized post-decongestion.
Keywords:
Acute decompensated heart failureDecongestionDiureticsHeart failure with reduced ejection fractionMore Related Videos
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:27Upper Respiratory Drugs: Decongestants
201
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
Most decongestants are readily available over-the-counter in...
201
01:26Heart Failure Drugs: Inotropic Agents
564
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K